Kirsty (insulin aspart)

pCPA File Number: 21631

Negotiation Status:

Concluded without agreement

Indication(s):

Diabetes Mellitus, Type 1 & 2

Sponsor/Manufacturer:

BGP Pharma ULC, d.b.a. Viatris Canada

CDA-AMC Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2022-02-28

Negotiation Process Concluded:

2022-06-01